Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Mechanism-Inspired Biomaterials and Regenerative Therapies for Radiation-Induced Skin Injury

Zhou Y., Zhang X., Shen X., Xing S., Yuan Y., Tian W.

Narrative Review on Chronic Wound, published in Int J Nanomedicine (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Nanomedicine (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41858581
PMCID
PMC12998469
DOI
10.2147/ijn.s568923

Abstract (original English)

Radiation-induced skin injury (RISI) represents the most common complication of cancer radiotherapy, severely impairing patient health and treatment adherence. Conventional therapies show limited benefits due to the complex pathological mechanisms of RISI, creating an urgent demand for more effective approaches. Emerging biomaterials and regenerative therapies offer new opportunities for intervention. This review first outlines the key mechanisms of RISI and then highlights the mechanism-driven biomaterial design, with particular focus on the rational selection of active ingredients and advanced delivery systems. We also examine regenerative therapies such as stem cell therapy and mitochondrial transplantation, emphasizing their potential to restore function at cellular or organelle levels. Finally, the major challenges and future directions of these therapeutic strategies in RISI treatment are discussed.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
SkinAnimalsHumansRadiodermatitisRadiation InjuriesBiocompatible MaterialsRegenerative Medicine

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research